After Symyx Terminates Acquisition Discussions, Certara Submits Proposal for $5.75 per Share

The new offer, worth around $200 million, comes as Symyx prepares to finalize its previously disclosed merger with Accelrys, which values Symyx at $178 million.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.